In silico drug discovery
The use of computer simulations to identify small molecule and other potential therapeutic drug candidates.
A trillion floating-point operations per second.
General-Purpose computing on Graphic Processing Units. Technology that employs special processors originally used in graphic processing for general computational applications other than graphics processing.
 One of Japan's largest systems
Combining CPUs and GPGPUs, the system has theoretical peak performance of over 480 teraflops, making it the largest private cloud environment for in silico drug discovery in Japan, according to Fujitsu's research as of December 19, 2013.
Fujitsu Exabyte File System.
 K computer
The K computer, which was jointly developed by RIKEN and Fujitsu, is part of the High-Performance Computing Infrastructure (HPCI) initiative led by Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT). It is a supercomputer with a computing speed of over 10 petaflops, and its availability for shared use began in September 2012.
Remote Virtual Environment Computing. A technology for high-speed display of virtual desktops developed by Fujitsu Laboratories.
 SINET4 Science Information Network
An information and communication network connecting universities and research institutions throughout Japan constructed and operated by the National Institute of Informatics.
 Small molecule drug design and evaluation technology
Fujitsu's original technologies, such as OPMF, which is software for designing small molecule compounds that target proteins underlying specific disease indications, and MAPLE CAFEE, which is software for predicting the activity of drug candidate compounds with a level of accuracy equivalent to biochemical assays.
Fujitsu is the leading Japanese information and communication technology (ICT) company offering a full range of technology products, solutions and services. Approximately 170,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE:6702) reported consolidated revenues of 4.4 trillion yen (US$47 billion) for the fiscal year ended March 31, 2013. For more information, please see http://www.fujitsu.com.
All company or product names mentioned herein are trademarks or registered trademarks of their respective owners. Information provided in this press release is accurate at time of publication and is subject to change without advance notice.
Date: 19 December, 2013
Company: Fujitsu Limited, , , , , , , , , , , , ,